Form 4 for RLI RLI CORP
Accepted 2024-11-27 00:00:00 ET · period of report 2024-11-26 · accession 0001415889-24-027846 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-11-27 | 2024-11-26 | RLI | Klobnak Jennifer L | COO | M - OptEx | $75.66 | +20.0K | 60.2K | +50% | +$1.51M |
| D | 2024-11-27 | 2024-11-26 | RLI | Klobnak Jennifer L | COO | F - Tax | $180.89 | -13.5K | 46.7K | -22% | -$2.45M |
| D | 2024-11-27 | 2024-11-26 | RLI | Klobnak Jennifer L | COO | M - OptEx | $0.00 | -20.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-26 | M | A | 20,000 | $75.66 | 60,245.17 | D | — | — | (F1) Balance reflects dividend reinvestment. |
| 2 | Common | Common Stock | 2024-11-26 | F | D | 13,520 | $180.89 | 46,725.17 | D | — | — | |
| 3 | Derivative | Stock Option | 2024-11-26 | M | D | 20,000 | $0.00 | 0 | D | $75.66 · 2020-05-02 to 2027-05-02 | 20,000 Common Stock | (F3) Stock option grant price adjusted to reflect $7.00 extraordinary dividend declared 11-10-2022. (F4) Pursuant to option schedule wherein 20% of the aggregate number of shares granted may be exercised commencing one year from grant date and each year thereafter in 20% increments. |